3 CARBOXAMIDO-5-ARYL-ISOXAZOLES

[mjhealthtips]

3-Carboxamido-5-aryl-isoxazoles as new CB2 agonists for the treatment of colitis (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23849204

Switching cannabinoid response from CB2 agonists to FAAH inhibitors (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24508127